ProfileGDS4177 / 231431_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 78% 84% 90% 89% 77% 84% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated172.6778
GSM603099KU-812 non-treated288.0684
GSM603098KCL-22 Imatinib-treated526.7190
GSM603097KCL-22 non-treated473.989
GSM603102JURL-MK1 Imatinib-treated158.2377
GSM603101JURL-MK1 non-treated278.6984